TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | -2 | -15 | -25 | -35 | -41 | -20 |
| S | %wins | 67 | 67 | 100 | 100 | 100 | 100 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/21/09 19:33 | 12/18/09 | CYTK | Cytokinetics Inc | Health | Drug | Pharmaceutical Preparations | Rabson Michael | CA | O | SVP Busi | M.d | 28 | 1.85 | 0 | 15 | 297 | 20 | D | -48 | 6 | 2 | -45 | -19 | -15 | -16 | -12 | 10 | 8 | 18 | 34 | 1 | -16 | |
5/4/07 17:37 | 5/3/07 | MAXY | Maxygen Inc | DE | Health | Biolab | Commercial Physical & Biologi | Rabson Michael | CA | O | SVP | S | -19 | 10.58 | 2 | -2 | 0 | 365 | I | 43 | 30 | 21 | -4 | -4 | -2 | -5 | -1 | -1 | -6 | -14 | -26 | -30 | -44 |
4/18/07 16:21 | 4/16/07 | MAXY | Maxygen Inc | DE | Health | Biolab | Commercial Physical & Biologi | Rabson Michael | CA | O | SVP | S | -20 | 10.89 | 2 | -2 | 0 | 367 | I | 46 | 43 | 39 | 1 | 6 | 8 | 1 | 9 | -3 | -3 | -15 | -23 | -37 | -39 |
12/15/04 14:03 | 12/15/04 | MAXY | Maxygen Inc | DE | Health | Biolab | Commercial Physical & Biologi | Rabson Michael | CA | O | SVP | S | -24 | 12.17 | 1 | -2 | -31 | 4 | D | 46 | 14 | 28 | 22 | 22 | 16 | 17 | 6 | 3 | 2 | -16 | -26 | -38 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |